
SABSW
USDSAB Biotherapeutics Inc. Warrant
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$0.048
Máximo
$0.039
Mínimo
$0.028
Volumen
0.01M
Fundamentos de la Empresa
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other
SAB BIO to Participate in Upcoming Investor Conferences
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its
Acciones Relacionadas
SHPH
Shuttle Pharmaceuticals Holdings Inc.
STK
Columbia Seligman Premium Technology Growth Fund Inc
VTR
Ventas Inc.
DECA
Denali Capital Acquisition Corp. Ordinary Shares
GOOD
Gladstone Commercial Corporation Real Estate Investment Trust
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.